Vertex Pharmaceuticals INC / Ma (VRTX) — 8-K Filings

8-K Filings (17)

• 8-K Filing — Nov 3, 2025
• Vertex Pharmaceuticals Files 8-K on Financials and Personnel — Aug 4, 2025 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on August 4, 2025, reporting on results of operations, financial condition, and changes in its board and office
• Vertex Pharmaceuticals Files 8-K — May 19, 2025 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on May 19, 2025, reporting "Other Events." The filing does not contain specific details about the nature of the
• Vertex Pharmaceuticals Files 8-K on Shareholder Votes — May 14, 2025 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on May 14, 2025, to report on matters submitted to a vote of its security holders. The filing details the compa
• Vertex Pharmaceuticals Files 8-K on Financials — May 5, 2025 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on May 5, 2025, to report on its results of operations and financial condition, as well as to file financial st
• Vertex Pharmaceuticals Files 8-K — Mar 28, 2025 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on March 28, 2025, to report other events. The filing does not contain specific details about the nature of the
• Vertex Pharmaceuticals Director Departs; Financials Filed — Feb 10, 2025 Risk: low
  Vertex Pharmaceuticals Incorporated announced on February 4, 2025, the departure of Dr. Paul J. W. Stone, a member of its Board of Directors. The company also r
• Vertex Pharmaceuticals Files 8-K Disclosure — Dec 20, 2024 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on December 20, 2024, to report information under Regulation FD. The filing does not contain specific details a
• Vertex Pharmaceuticals Files 8-K on Financials — Nov 4, 2024 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on November 4, 2024, reporting on its results of operations and financial condition, as well as financial state
• Vertex Pharmaceuticals Enters Material Definitive Agreement — Aug 16, 2024 Risk: medium
  On August 15, 2024, Vertex Pharmaceuticals Incorporated entered into a material definitive agreement. The filing does not disclose the specific details of this
• Vertex Pharmaceuticals Files 8-K on Financials — Aug 1, 2024 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on August 1, 2024, reporting on its results of operations and financial condition, as well as financial stateme
• Vertex Pharmaceuticals Files Routine 8-K — Jun 27, 2024 Risk: low
  On June 27, 2024, Vertex Pharmaceuticals Incorporated filed an 8-K report. The filing indicates no specific material events or transactions requiring immediate
• Vertex Pharmaceuticals Files 8-K — May 20, 2024 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on May 20, 2024, to report other events and financial statements. The filing details the company's principal ex
• Vertex Pharmaceuticals Files 8-K on Shareholder Vote Matters — May 15, 2024 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on May 15, 2024, to report on the submission of matters to a vote of security holders. The filing indicates tha
• Vertex Pharmaceuticals Files 8-K on Financials — May 6, 2024 Risk: low
  Vertex Pharmaceuticals Incorporated filed an 8-K on May 6, 2024, reporting on its results of operations and financial condition. The filing includes financial s
• Vertex Pharmaceuticals Enters Material Definitive Agreement — Apr 11, 2024 Risk: medium
  On April 10, 2024, Vertex Pharmaceuticals Incorporated entered into a Material Definitive Agreement. The filing also includes information on Other Events and Fi
• Vertex Pharma Files 8-K on Financial Results, Operations — Feb 5, 2024
  Vertex Pharmaceuticals Incorporated filed an 8-K on February 5, 2024, to announce its results of operations and financial condition. This filing indicates that

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX